Prescription medicine determinations and designations

Find out more about Prescription medicines determination and designation notices

Use the filters below to narrow your search.

Filters applied:

Orphan Drug

11 result(s) found, displaying 1 to 11

Notice for tafasitamab (Specialised Therapeutics Alim Pty Ltd)

25 October 2024

Designation or determination

Orphan Drug
Notice for dexrazoxane (Maxx Pharma Pty Ltd)

11 October 2024

Designation or determination

Orphan Drug
Notice for dexrazoxane (Maxx Pharma Pty Ltd)

4 October 2024

Designation or determination

Orphan Drug
Notice for dordaviprone (Biointelect Pty Ltd)

25 September 2024

Designation or determination

Orphan Drug
Notice for omaveloxolone (Biogen Australia Pty Ltd)

14 May 2024

Designation or determination

Orphan Drug
Notice for Tarlatamab (Amgen Australia Pty Ltd)

13 March 2024

Designation or determination

Orphan Drug
Notice for Ivacaftor (Vertex Pharmaceuticals Australia Pty Ltd)

16 November 2023

Designation or determination

Orphan Drug
Notice for anacaulase-bcdb (Nexo Pharmaceuticals Pty Ltd)

28 August 2023

Designation or determination

Orphan Drug
Notice for vutrisiran (Alnylam Australia Pty Ltd)

28 August 2023

Designation or determination

Orphan Drug
Notice for zolbetuximab (Astellas Pharma Australia Pty Ltd)

9 August 2023

Designation or determination

Orphan Drug
Notice for lumasiran (Alnylam Australia Pty Ltd)

27 July 2023

Designation or determination

Orphan Drug